Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to compare two different techniques to perform the standard of care surgery to treat prostate cancer. This surgery is called robotic radical prostatectomy. There are two robotic surgical systems approved by the Food and Drug Administration (FDA) to perform this surgery. First system is called the Da Vinci ® Xi system. With this system, six small incisions are made during the surgery. Second system is called the Da Vinci ® SP system. With this system a single incision is made during the surgery. Same surgery is done with each surgical system. This study aims to understand whether a single incision surgery ends up with better recovery after surgery.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04696263
Study type Interventional
Source Case Comprehensive Cancer Center
Contact
Status Suspended
Phase N/A
Start date September 1, 2022
Completion date June 1, 2025

See also
  Status Clinical Trial Phase
Active, not recruiting NCT01764646 - Hypofractionated Radiation Therapy in Prostate Cancer N/A
Recruiting NCT04534075 - Dietary Fiber During Radiotherapy - a Placebo-controlled Randomized Trial Phase 3
Withdrawn NCT04765423 - Fluciclovine (Axumin) PET/CT vs. NaF PET/CT in Prostate Cancer Osseous Metastatic Disease N/A
Not yet recruiting NCT06150417 - MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA) Phase 2